Cancer Care at the Crossroads 2017 Program

The Second One-Day International Summit on Innovation, Clinical Benefit and Cost New York Genome Center

DATE & TIME

Friday,

March 17, 2017

8:00am - 4:15pm

LOCATION

New York Genome Center,

101 Avenue of the Americas,

New York, NY

OPENING REMARKS:
Setting the Stage for the Day
8:00am - 8:15am

Mike Meyer

President, Meyer Consulting

Stephen Emerson

MD, PhD, Director, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center

ROUND TABLE 1
Cancer Care through the Lens of Health Plans, Academic Centers, Pharma and Provider Groups - What Has Happened in the last 12 months
8:15am - 9:30am

Moderator

Stephen Emerson

MD, PhD, Director, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center

Panelist

Cliff Hudis

MD, CEO, American Society of Clinical Oncology (ASCO)

Panelist

Jeffrey Le Benger

MD, Chairman and CEO, Summit Medical Group & Summit Health Care Management

Panelist

Mace Rothenberg

MD, Senior Vice President, Clinical Development Officer, Oncology, Pfizer Global Product Development, Pfizer Inc

Panelist

Maureen Sullivan

Chief Strategy Officer and Innovation Officer, Blue Cross and Blue Shield Association

ROUND TABLE 2
The Future of Cancer Treatment (Genomics, Precision Medicine and Immunotherapy) and Genomics/Analytics Driven Decision Making
9:35am - 11:00am

Moderator

Alexander Eggermont

MD, PhD, Director, Gustave Roussy; Chairman, Cancer Core Europe

Panelist

Razelle Kurzrock

MD, Senior Deputy Director, Moores Cancer Center, UCSD

Panelist

Gerald Batist

MD, CM Director, McGill Cancer Research Center

Panelist

Jeffrey S. Weber

MD, PhD, Deputy Director, Laura and Isaac Perlmutter Cancer Center, NYU

Panelist

Gideon Bosker

MD, Co-Founder and Chief Executive Officer, Darwin Health

ROUND TABLE 3
Innovations and Challenges Facing Diagnosis, Integrated Care, Survivorship Programs and Palliative Care - Patient and Media Perceptions
11:00am - 12:15pm

Moderator

Mike Meyer

President, Meyer Consulting

Panelist

Frances M. Visco

President, National Breast Cancer Coalition

Panelist

Alan Bryce

MD, Vice Chair, Division of Hematology and Medical Oncology, Mayo Clinic of Arizona, Medical Director, Genomic Oncology Clinic, Mayo Clinic Arizona

Panelist

Mary Ann Christopher

Vice President, Clinical Operations & Transformation, Horizon Blue Cross Blue Shield of New Jersey

Panelist

Michael J. Fisch

MD, Medical Director of Oncology, AIM Specialty Health; Former Chair, Department of General Oncology, MD Anderson Cancer Center

LUNCH SERVED AT CONFERENCE CENTER
12:00pm - 1:15pm
ROUND TABLE 4
The Challenges Facing Health Plans, Providers and Governments in Financing Innovative Cancer Treatments in a Changing Health Care Policy Environment
1:15pm - 2:30pm

Moderator

Peter S. Fine

President and CEO, Banner Health

Panelist

Harold Paz

MD MS, Executive Vice President and Chief Medical Officer, Aetna

Panelist

Indranil Bagchi

PhD, Vice President and Head, Payer Insights and Access, Patient & Health Impact, Pfizer Inc

Panelist

Glen Stettin

MD, Chief Innovation Officer & Senior Vice President - Clinical, Research & New Solutions, Express Scripts

Panelist

Richard Sullivan

MD, PhD, Director, Institute of Cancer Policy; Co-Director, Conflict & Health Research Program, King's College London

ROUND TABLE 5
Cancer Care Delivery: Providing the Right Care at the Right Place at the Right Time; Lessons Learned From New Models of Care
2:40pm - 3:50pm

Moderator

Jacque Sokolov

MD, Chairman and CEO, SSB Solutions

Panelist

David Nanus

Director of New York Presbyterian Hospital - Weill Cornell Medicine Healthcare Services Cancer Program; Chief, Division of Hematology and Medical Oncology, Weill Cornell Medicine and New York Presbyterian

Panelist

Jose Francisco Tomas Martinez

MD, Medical Executive Director, Sanitas/ BUPA, Spain

Panelist

Richard R. Barakat

MD, Director, Regional Care Network; Vice Chair, Regional Care Network and Affiliations, Department of Surgery, Memorial Sloan Kettering Cancer Center

Panelist

Robert Miller

MD, Vice President and Medical Director, CancerLinQ, American Society of Clinical Oncology (ASCO)

CLOSING REMARKS
3:50pm - 4:15pm